top of page

PUBLISHED WORK

  • Prayag PS, Soman RN, Panchakshari SP, Ajapuje PS, Mahale NP, Dhupad S, et al. Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India. Indian J Crit Care Med 2023;27(4):260–264.

  • Griesharber Philip, Patel Amrita, Farber John. Cystic Medial Degeneration and Medial Smooth Muscle Degeneration are Distinct Clinicopathologic Entities in the Pathogenesis of Dissecting Aneurysms of the Aorta. Archives of Pathology and Laboratory Medicine, 135: 1543-2165, 2011.

  • Kundur S, Prayag A, Selvakumar P, Nguyen H, McKee L, Cruz C, Srinivasan A, Shoyele S, Lakshmikuttyamma A. Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines. Journal of cellular physiology. 2019 Jul;234(7):11103-18.

  • Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients. Clinical Infectious Diseases. 2019 May 2;68(10):1641-9.

  • Foolad F, Prayag A, Ghantoji SS, Ariza-Heredia EJ, Chemaly RF. Use of oral ribavirin for the treatment of RSV infections in Hematopoietic Cell Transplant (HCT) recipients. Biology of Blood and Marrow Transplantation. 2017 Mar 1;23(3):S189.

  • El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K. The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients. The Journal of infectious diseases. 2019 Feb 23;219(6):898-907.

  • Kmeid J, Kulkarni PA, Batista MV, El Chaer F, Prayag A, Ariza-Heredia EJ, Mulanovich VE, Chemaly RF. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014. BMC infectious diseases. 2019 Dec;19:1-8.

  • Artau A, Aitken SL, Batista M, Chaer FE, Prayag A, Haddad LE, Mulanovich V, Ariza-Heredia E, Chemaly R. 1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. InOpen Forum Infectious Diseases 2018 Nov (Vol. 5, No. suppl_1, pp. S486-S486). US: Oxford University Press.

  • Artau A, Aitken SL, El Chaer F, Prayag A, El Haddad L, Mulanovich VE, Shah DP, Ariza-Heredia EJ, Chemaly RF. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 2018 Mar 1;24(3):S385-6.

  • Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji SS, Ariza-Heredia EJ, Chemaly RF. Impact of ribavirin formulation and host risk factors on 90-day mortality in Hematopoietic Cell Transplant (HCT) patients with RSV infection. Biology of Blood and Marrow Transplantation. 2018 Mar 1;24(3):S369-70.

  • El Chaer F, Prayag A, El Haddad L, Mulanovich VE, Shah DP, Ariza-Heredia EJ, Chemaly RF. Drug-Resistant Cytomegalovirus Infections in Hematopoietic Cell Transplant Recipients: A Single Center Retrospective Study. Biology of Blood and Marrow Transplantation. 2017 Mar 1;23(3):S188-9.

  • Muthu V, Agarwal R, Rudramurthy SM, Thangaraju D, Shevkani MR, Patel AK, Shastri PS, Tayade A, Bhandari S, Gella V, Savio J. Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India. Emerging Infectious Diseases. 2023;29(1).

  • Mahale N, Rajhans P, Godavarthy P, Narasimhan VL, Oak G, Marreddy S, Bedekar A, Dhundi U, Pawar HS, Akole P, Pawar B. A retrospective observational study of hypoxic COVID-19 patients treated with immunomodulatory drugs in a tertiary care hospital. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2020 Nov;24(11):1020.

  • Prayag PS, Patwardhan S, Panchakshari S, Rajhans PA, Prayag A. The Dominance of Candida auris: A Single-center Experience of 79 Episodes of Candidemia from Western India. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2022 May;26(5):560.

  • Prayag PS, Patwardhan SA, Panchakshari SP, Prayag AP. Clostridium difficile in Oncology Patients—Review of Diagnosis and Management in the Indian Setting. Indian Journal of Medical and Paediatric Oncology. 2023 Mar 1.

  • Prayag PS, Panchakshari SP, Mahalle NP, Dhupad S, Patwardhan SA, Naik SS, Narawade S, Melinkeri S, Prayag AP. Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India. International Journal of Infectious Diseases. 2022 Nov 1;124:76-80.

  • Prayag PS, Purandare BD, Patwardhan SA, Pairaiturkar PP, Rege AJ, Bhave AV, Panchakshari SP, Raja PT, Melinkeri AS, Prayag AP. COVID-19 Associated Vertebral Osteomyelitis Caused by Aspergillus Species—A Case Series. Indian Journal of Orthopaedics. 2022 Jul;56(7):1268-76.

  • Prayag A. Overview and principles of scientific writing. Indian Journal of Medical and Paediatric Oncology. 2019 Jul;40(03):420-3.

  • Prayag A. Challenges in scientific writing. Indian Journal of Medical and Paediatric Oncology. 2019 Oct;40(04):554-5.

  • Kulkarni PS, Prayag A, Borker AS, Sirohi B. Let us eradicate all bias, gender included. Indian Journal of Medical and Paediatric Oncology. 2020 Jan;41(01):1-3.

  • Kulkarni PS, Gandhi SS, Dastane AM, Deshmukh CD, Hingmire S, Karve G, Prayag A, Kelkar D. Study of germline mutations in high risk cancer patients from a tertiary care center in India. Annals of Oncology. 2019 Nov 1;30:ix127-8.

bottom of page